UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The emergence proposal in quantum gravity and the species scale

The journal of high energy physics, 2023-06, Vol.2023 (6), p.47-131, Article 47

2023

Volltextzugriff (PDF)

Towers and hierarchies in the Standard Model from Emergence in Quantum Gravity

The journal of high energy physics, 2023-10, Vol.2023 (10), p.172-27, Article 172

2023

Volltextzugriff (PDF)

Entropy bounds and the species scale distance conjecture

The journal of high energy physics, 2024-01, Vol.2024 (1), p.39-66, Article 39

2024

Volltextzugriff (PDF)

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

The New England journal of medicine, 2022-02, Vol.386 (5), p.437-448

2022

Volltextzugriff (PDF)

Development of subcutaneous fat in Spanish and Latin American children and adolescents: Reference values for biceps, triceps, subscapular and suprailiac skinfolds

Homo, 2017-03, Vol.68 (2), p.145-155

2017

Volltextzugriff (PDF)

A gravitino distance conjecture

The journal of high energy physics, 2021-08, Vol.2021 (8), p.1-49, Article 92

2021

Volltextzugriff (PDF)

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions

Annals of oncology, 2017-04, Vol.28 (4), p.711-717

2017

Volltextzugriff (PDF)

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Journal of clinical oncology, 2017-08, Vol.35 (22), p.2558-2567

2017

Volltextzugriff (PDF)

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference

Annals of oncology, 2017-11, Vol.28 (suppl_8), p.viii30-viii35

2017

Volltextzugriff (PDF)

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

Gynecologic oncology, 2020-11, Vol.159 (2), p.442-448

2020

Volltextzugriff (PDF)

O008/#785 A multicenter, open-label, randomized, phase 3 study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775

International journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A4-A5

2021

Volltextzugriff (PDF)

O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors

International journal of gynecological cancer, 2021-11, Vol.31 (Suppl 4), p.A1-A2

2021

Volltextzugriff (PDF)

145 Characterization of adverse reactions in patients with advanced endometrial cancer (aec) receiving lenvatinib + pembrolizumab (Study 309/KEYNOTE-775)

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A78-A78

2021

Volltextzugriff (PDF)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

Clinical & translational oncology, 2021-05, Vol.23 (5), p.922-930

2021

Volltextzugriff (PDF)

Usefulness of Omalizumab in Rapid Drug Desensitization in Patients with Severe Anaphylaxis Induced by Carboplatin: Open Questions

Journal of investigational allergology & clinical immunology, 2020-01, Vol.30 (4), p.0-300

2020

Volltextzugriff (PDF)

Reply to M. Mo et al

Journal of clinical oncology, 2018-01, Vol.36 (3), p.303-303

2018

Volltextzugriff (PDF)

726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)

Annals of oncology, 2021-09, Vol.32, p.S729-S730

2021

Volltextzugriff (PDF)

Results of a Dose‐Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non–Small Cell Lung Cancer

Clinical pharmacology in drug development, 2021-10, Vol.10 (10), p.1142-1155

2021

Volltextzugriff (PDF)

Time without symptoms or toxicity in patients with recurrent ovarian cancer receiving niraparib maintenance treatment versus placebo: A TWIST analysis of the ENGOT24-OV16/NOVA trial

Gynecologic oncology, 2019-06, Vol.154, p.2-2

2019

Volltextzugriff (PDF)

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study

ESMO open, 2022-02, Vol.7 (1), p.100311-100311, Article 100311

2022

Volltextzugriff (PDF)

Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life

Supportive care in cancer, 2016-03, Vol.24 (3), p.1241-1249

2016

Volltextzugriff (PDF)

A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall

Annals of oncology, 2018-10, Vol.29, p.viii753-viii753

2018

Volltextzugriff (PDF)

Delta oscillations coordinate intra-cerebellar and cerebello-hippocampal network dynamics during sleep

The Journal of neuroscience, 2022-03, Vol.42 (11), p.2268-2281

2022

Volltextzugriff (PDF)

In vitro phagocytosis of carrier mouse red blood cells is increased by Band 3 cross-linking or diamide treatment

Biotechnology and applied biochemistry, 2001-12, Vol.34 (3), p.143-149

2001

Volltextzugriff (PDF)

Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for Stage IB2-IIB cervical cancer: EORTC55994

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A12-A12

2019

Volltextzugriff (PDF)

1 – 25 von 634

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(538)
Mit Volltextzugriff
(517)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The emergence proposal in quantum gravity and the species scale

Towers and hierarchies in the Standard Model from Emergence in Quantum Gravity

Entropy bounds and the species scale distance conjecture

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

Development of subcutaneous fat in Spanish and Latin American children and adolescents: Reference values for biceps, triceps, subscapular and suprailiac skinfolds

A gravitino distance conjecture

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

O008/#785 A multicenter, open-label, randomized, phase 3 study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer: study 309/keynote-775

O002/#43 Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aec): subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors

145 Characterization of adverse reactions in patients with advanced endometrial cancer (aec) receiving lenvatinib + pembrolizumab (Study 309/KEYNOTE-775)

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

Usefulness of Omalizumab in Rapid Drug Desensitization in Patients with Severe Anaphylaxis Induced by Carboplatin: Open Questions

Reply to M. Mo et al

726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)

Results of a Dose‐Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non–Small Cell Lung Cancer

Time without symptoms or toxicity in patients with recurrent ovarian cancer receiving niraparib maintenance treatment versus placebo: A TWIST analysis of the ENGOT24-OV16/NOVA trial

Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study

Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life

A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall

Delta oscillations coordinate intra-cerebellar and cerebello-hippocampal network dynamics during sleep

In vitro phagocytosis of carrier mouse red blood cells is increased by Band 3 cross-linking or diamide treatment

Results from neoadjuvant chemotherapy followed by surgery compared to chemoradiation for Stage IB2-IIB cervical cancer: EORTC55994

Suchergebnisse filtern